Navigation Links
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
Date:11/7/2011

ertolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
  • 1218 - Monday, November 7, 9:00 am - 6:00 pm, Poster Hall

  • Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis
    • 1220 - Monday, November 7, 9:00 am - 6:00 pm, Poster Hall

About Rheumatoid Arthritis

RA affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.

About Cimzia

Certolizumab pegol is the only PEGylated anti-TNF (Tumor Necrosis Factor).  It has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha.  Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation.  This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases.  The U.S. Food and Drug Administration (FDA) has approved certolizumab pegol for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy.  It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis.  Certolizumab pegol was approved in Switzerland for induction of a clinical response and for the maintenance of a clinical response and remission in p
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
4. Reportlinker Adds Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
8. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
9. Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital
10. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
11. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)...  Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing ... today announced that James A. Joyce , Aethlon ... overview at the 27th Annual ROTH Conference on March ... previously scheduled to present at 5:30 pm Pacific on ... at The Ritz-Carlton Hotel in Laguna Niguel, ...
(Date:3/6/2015)... , March 6, 2015  Par Pharmaceutical ... a conference call on Friday, March 13, 2015 ... of operations for the fourth quarter and full ... held and currently makes certain financial information available ... Securities and Exchange Commission and will make certain ...
(Date:3/6/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... payment from Biogen Idec related to advancing the ongoing ... infants with spinal muscular atrophy (SMA).  ... is a randomized, double-blind, sham-procedure controlled thirteen month study ... will evaluate the efficacy and safety of a 12 ...
Breaking Medicine Technology:Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5
... PARSIPPANY, N.J., Jan. 11 Survival of the fittest? ... not only what you know today, but what you need ... Whoever has the right insight and accurate forecasting skills will ... (and growing) market in the world, its sheer size also ...
... Calif., Jan. 11 Derycz Scientific (OTC Bulletin Board: DYSC), a ... of information from content publishers to enterprise customers and their constituents, ... the website of DDN ( Drug Discovery News ). ... is titled "Speeding the Path to FDA Approval in the Era ...
Cached Medicine Technology:Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010 2Derycz Scientific Featured In DDN (Drug Discovery News) 2Derycz Scientific Featured In DDN (Drug Discovery News) 3
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 ... of “Women’s Health,” a campaign that seeks to educate, ... role when it comes to their health and their ... the rise, it has never been more pertinent to ... rights. , The print component of “Women’s Health” ...
(Date:3/6/2015)... March 06, 2015 As healthcare ... images and content from disparate systems, they are ... care and increase efficiency. Enterprise content management ... content with core IT solutions, including electronic medical ... existing IT applications. , The following organizations ...
(Date:3/6/2015)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Mallory Sofastaii, a mobile ... and shared with viewers how this is a fully immersive ... mobile games have benefited from building in a social media ... to connect their games to Facebook, see what level their ...
(Date:3/6/2015)... Saving Moses, a global humanitarian organization ... traveling to Angola, Africa March 7-14 to visit malnutrition ... , This will be the organizations fifth time to ... commitment to the region’s population by saving infants and ... with the mothers and babies of the malnutrition program, ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... at the Moda Center. After being away from the ... showing no signs of letting up on his “Garth Brooks ... his wife, Trisha Yearwood, to venues around the United States. ... critically acclaimed tour to the Moda Center in Portland, OR. ...
Breaking Medicine News(10 mins):Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3
... Curative ... Therapy Driving Growth, ARCADIA, Calif., Oct. 3 ... Program for Los Angeles, a,ranking of the 50 fastest growing technology, ... Touche USA LLP, one,of the nation,s leading professional services organizations. Rankings ...
... CHICAGO, Oct. 3 President Bush,s veto today,of ... for millions of,children from families with low incomes ... dental health, says Oral Health America, a national,advocacy ... ten million children eligible for coverage through a,bipartisan, ...
... Citys infant mortality rate widely regarded as a barometer ... the Health Department reported today. The rate in 2006 was ... the previous year. The City has made major progress in ... was double what it is today, but the decline has ...
... faculty has received a five-year, $8.4 million grant from ... to survey the genetic, physical and behavioral profiles of ... the reach and ethnic diversity of the Autism Genetic ... research, overseen by Clara Lajonchere, research assistant professor at ...
... WASHINGTON, Oct. 3 The United States,Conference of ... H.,Palmer, today expressed shock and disbelief at President Bush,s ... Insurance Program known as,SCHIP. With his action, 10 million ... protection., "We are extremely disappointed because this is ...
... The California Nurses,Association/National Nurses Organizing Committee today condemned ... Children,s Health Insurance,Program. "Listening to the overheated rhetoric ... Rove may be gone but his legacy lives on," ... Presidents. She chastised,Bush for his recent claims that legislators ...
Cached Medicine News:Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 2Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 3Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 4Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2Health News:New York City's infant mortality rate declined in 2006 2Health News:New York City's infant mortality rate declined in 2006 3Health News:New York City's infant mortality rate declined in 2006 4Health News:USC granted $8.4 million for autism research 2Health News:USC granted $8.4 million for autism research 3Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2
... The CA-1000 counts a Petri dish in ... the optical characteristics of the colonies as ... CA-1000 is equipped with three types of ... lighter or darker than the agar and ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... sophisticated whole blood analysis system that is ... satisfying the stringent requirements of the central ... all of the components of a traditional ... sampling unit, all of the sensors and ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: